Personal profile
Biography
Professor Peter Flatt holds a BSc Hons and PhD from Aston University. He was a Research Fellow at the University of Uppsala, Sweden (1978-80) before taking up an academic appointment at Surrey University in 1980 . He is currently Professor of Biomedical Sciences at Ulster University, a position that he has held since 1989.Professor Flatt is Head of the Diabetes Research Group, having served as Director of Biomedical Sciences Research Centre (1992-94) and Head of the School of Biomedical Sciences (1994-97).He is author of over 500 full scientific peer-reviewed papers (h-index 55) on various aspects of diabetes and editor of four major diabetes research texts including New Antidiabetic Drugs (Smith-Gordon, 1990) and Nutrient Regulation of Insulin Secretion (Portland Press, 1992).
Professor Flatt is founding Chairman (1991-) of the Islet Study Group of the European Association for the Study of Diabetes (EASD), member of the EASD Council (1997-01), Scientific Secretary and Committee Member of Diabetes UK (1991-97; 2001-04) and a member of the Grants Review Board of the Juvenile Diabetes Federation International (1996-99).
He is a recipient of the Mary Jane Kugal Award (1999) of Juvenile Diabetes Federation International, Biochemical Society Medal (2005), and was elected to membership of Royal Irish Academy (2006), Ulster University Distinguished Senior Research Fellowship (2006) and Diabetes UK Dorothy Hodgkin Award Lecturer (2008). Patent holder, Academic co-founder and Chief Scientific Officer/Director of Diabetica Ltd.
Research Interests
Insulin secretion; pancreatic islet cell function and demise antidiabetic drugs and gene therapy; Brain and gut peptides
Teaching Interests
Endocrinology; Physiology;
Administrative Roles:
Head Diabetes Research Group
Course Director BSc Hons
Biomedical Science Undergraduate Programmes
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Cafeteria diet compromises natural adaptations of islet cell transdifferentiation and turnover in pregnancy
Dubey, V., Tanday, N., Irwin, N., Tarasov, A. I., Flatt, P. R. & Moffett, R. C., 31 Jan 2025, In: Diabetic Medicine . 42, 1, p. 1-9 10 p., e15434.Research output: Contribution to journal › Article › peer-review
Open AccessFile2 Link opens in a new tab Citations (Scopus)52 Downloads (Pure) -
Islet effects of cholecystokinin and exploitation in diabetes
Tanday, N., Irwin, N. & Flatt, P., Jan 2025, Cholecystokinin: from Gallbladder to Cognition and Beyond. Feinle-Bisset, C. & F.Rehfeld, J. (eds.). Academic Press, p. 305-325 21 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
2 Link opens in a new tab Citations (Scopus) -
Kisspeptin-10 Ameliorates Obesity-Diabetes with Diverse Effects on Ileal Enteroendocrine Cells and Pancreatic Islet Morphology in High-Fat Fed Female Mice
Sridhar, A., Khan, D., Muthukumar, R., Sampathkumar, S., Irwin, N., Flatt, P. R. & Moffett, R. C., 30 Nov 2025, In: Biomolecules. 15, 11, p. 1-15 15 p., 1591.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Downloads (Pure) -
Therapeutic Potential of Medicinal Plants and Their Phytoconstituents in Diabetes, Cancer, Infections, Cardiovascular Diseases, Inflammation and Gastrointestinal Disorders
Ansari, P., Reberio, A. D., Ansari, N. J., Kumar, S., Khan, J. T., Chowdhury, S., Abd El-Mordy, F. M., Hannan, J. M. A., Flatt, P. R., Abdel-Wahab, Y. H. A. & Seidel, V., 12 Feb 2025, In: Biomedicines. 13, 2, p. 1-40 40 p., 454.Research output: Contribution to journal › Review article › peer-review
Open AccessFile47 Link opens in a new tab Citations (Scopus)170 Downloads (Pure) -
[ P3 ] PP, a stable, long‐acting pancreatic polypeptide analogue, evokes weight lowering and pancreatic beta‐cell‐protective effects in obesity‐associated diabetes
Tanday, N., Zhu, W., Tarasov, A. I., Flatt, P. R. & Irwin, N., 30 Nov 2024, In: Diabetes, Obesity and Metabolism. 26, 11, p. 4945-4957 13 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Link opens in a new tab Citation (Scopus)66 Downloads (Pure)
Thesis
-
Gut hormones and peptide therapeutics for diabetes
Flatt, P. R. (Author), Mar 2018Student thesis: Doctoral Thesis
File
Profiles
-
Optimising GPCR Drug Candidates: A Path to Investor-Ready Commercial Development for diabetes, obesity and cardiometabolic conditions
McKillop, A. (PI) & Flatt, P. (CoI)
17/11/25 → 17/11/27
Project: Research
-
Harnessing the glucose lowering actions of alpha-melanocyte stimulatory hormone as a potential new treatment for people with type 2 diabetes mellitus (HSC R&D Co-Funding for JDRF)
Miras, A. (PI), le Roux, C. (CoI), Swan, P. (CoI), Flatt, P. (CoI), Price, R. (CoI) & Gault, V. (CoI)
Health and Social Care R&D Division of the Public Health Agency for Northern Ireland
1/01/24 → 31/12/26
Project: Research
-
Resting beta-cells to reduce their metabolic demand and improve enduring glycaemic control
Irwin, N. (PI), Tarasov, A. (CoI) & Flatt, P. (CoI)
1/09/23 → 31/05/27
Project: Research
-
Obesity treatments to improve diabetes
Flatt, P. (CoI), le Roux, C. (PI) & Gault, V. (CoI)
1/12/20 → 31/10/28
Project: Research
-